{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:19:41Z","timestamp":1792120781999,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sirtuin 1 (SIRT1) activity is neuroprotective, and we have recently demonstrated its role in the retrograde degenerative process in motoneurons (MNs) in the spinal cord of rats after peripheral nerve root avulsion (RA) injury. SIRT2 has been suggested to exert effects opposite those of SIRT1; however, its roles in neurodegeneration and neuron response after nerve injury remain unclear. Here we compared the neuroprotective potentials of SIRT1 activation and SIRT2 inhibition in a mouse model of hypoglossal nerve axotomy. This injury induced a reduction of around half MN population within the hypoglossal nucleus by a non-apoptotic neurodegenerative process triggered by endoplasmic reticulum (ER) stress that resulted in activation of the unfolded protein response mediated by IRE1\u03b1 and XBP1 by 21 days post injury. Both SIRT1 activation with NeuroHeal and SIRT2 inhibition with AK7 protected NSC-34 motor neuron-like cells against ER stress in vitro. In agreement with the in vitro results, NeuroHeal treatment or SIRT1 overexpression was neuroprotective of axotomized hypoglossal MNs in a transgenic mouse model. In contrast, AK7 treatment or <jats:italic>SIRT2<\/jats:italic> genetic depletion in mice inhibited damaged MN survival. To resolve the in vitro\/in vivo discrepancies, we used an organotypic spinal cord culture system that preserves glial cells. In this system, AK7 treatment of ER-stressed organotypic cultures was detrimental for MNs and increased microglial nuclear factor-\u03baB and the consequent transcription of cytotoxic pro-inflammatory factors similarly. The results highlight the importance of glial cells in determining the neuroprotective impact of any treatment.<\/jats:p>","DOI":"10.1038\/s41419-018-0553-6","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T08:19:19Z","timestamp":1525940359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3368-9302","authenticated-orcid":false,"given":"David","family":"Romeo-Guitart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0359-0045","authenticated-orcid":false,"given":"Tatiana","family":"Leiva-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Espinosa-Alcantud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8735-4156","authenticated-orcid":false,"given":"Alejandro","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Dom\u00ednguez- Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-6321","authenticated-orcid":false,"given":"Caty","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"553_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrn3680","volume":"15","author":"L Conforti","year":"2014","unstructured":"Conforti, L., Gilley, J. & Coleman, M. P. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat. Rev. Neurosci. 15, 394\u2013409 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"553_CR2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/cdd.2011.24","volume":"18","author":"C Penas","year":"2011","unstructured":"Penas, C. et al. Autophagy, and BiP level decrease are early key events in retrograde degeneration of motoneurons. Cell Death Differ. 18, 1617\u20131627 (2011).","journal-title":"Cell Death Differ."},{"key":"553_CR3","doi-asserted-by":"crossref","DOI":"10.1038\/srep09185","volume":"5","author":"C Casas","year":"2015","unstructured":"Casas, C. et al. Network-based proteomic approaches reveal the neurodegenerative, neuroprotective and pain-related mechanisms involved after retrograde axonal damage. Sci. Rep. 5, 9185 (2015).","journal-title":"Sci. Rep."},{"key":"553_CR4","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1038\/s41598-017-11086-3","volume":"7","author":"D Romeo-Guitart","year":"2017","unstructured":"Romeo-Guitart, D., Fores, J., Navarro, X. & Casas, C. Boosted regeneration and reduced denervated muscle atrophy by NeuroHeal in a pre-clinical model of lumbar root avulsion with delayed reimplantation. Sci. Rep. 7, 12028\u201312040 (2017).","journal-title":"Sci. Rep."},{"key":"553_CR5","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41598-018-19767-3","volume":"8","author":"D Romeo-Guitart","year":"2018","unstructured":"Romeo-Guitart, D. et al. Neuroprotective drug for nerve trauma revealed using artificial intelligence. Sci. Rep. 8, 1879\u20131894 (2018).","journal-title":"Sci. Rep."},{"key":"553_CR6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13105-016-0492-6","volume":"72","author":"W Kupis","year":"2016","unstructured":"Kupis, W., Pa\u0142yga, J., Tomal, E. & Niewiadomska, E. The role of sirtuins in cellular homeostasis. J. Physiol. Biochem. 72, 371\u2013380 (2016).","journal-title":"J. Physiol. Biochem."},{"key":"553_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/bbrc.2000.3000","volume":"273","author":"RA Frye","year":"2000","unstructured":"Frye, R. A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793\u2013798 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"553_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/13543776.2014.982532","volume":"25","author":"P Mellini","year":"2015","unstructured":"Mellini, P., Valente, S. & Mai, A. Sirtuin modulators: an updated patent review (2012\u20132014). Expert Opin. Ther. Pat. 25, 5\u201315 (2015).","journal-title":"Expert Opin. Ther. Pat."},{"key":"553_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","volume":"13","author":"RH Houtkooper","year":"2012","unstructured":"Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell. Biol. 13, 225\u2013238 (2012).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"553_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","volume":"25","author":"HC Chang","year":"2014","unstructured":"Chang, H.-C. & Guarente, L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25, 138\u2013145 (2014).","journal-title":"Trends Endocrinol. Metab."},{"key":"553_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2011.09.004","volume":"20","author":"H Kim","year":"2011","unstructured":"Kim, H. et al. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC\/C activity. Cancer Cell 20, 487\u2013499 (2011).","journal-title":"Cancer Cell"},{"key":"553_CR12","doi-asserted-by":"crossref","first-page":"e0116919","DOI":"10.1371\/journal.pone.0116919","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson\u2019s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS ONE 10, e0116919 (2015).","journal-title":"PLoS ONE"},{"key":"553_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.braindev.2009.05.006","volume":"32","author":"AM Lavezzi","year":"2010","unstructured":"Lavezzi, A. M., Corna, M., Mingrone, R. & Matturri, L. Study of the human hypoglossal nucleus: Normal development and morpho-functional alterations in sudden unexplained late fetal and infant death. Brain Dev. 32, 275\u2013284 (2010).","journal-title":"Brain Dev."},{"key":"553_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.braindev.2009.12.001","volume":"32","author":"M Hayashi","year":"2010","unstructured":"Hayashi, M. Is developmental neuropathology of the motor neurons the key to resolving the mystery in motor neuron diseases? Brain Dev. 32, 265\u2013267 (2010).","journal-title":"Brain Dev."},{"key":"553_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.051508.135722","volume":"33","author":"KC Kanning","year":"2010","unstructured":"Kanning, K. C., Kaplan, A. & Henderson, C. E. Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 33, 409\u2013440 (2010).","journal-title":"Annu. Rev. Neurosci."},{"key":"553_CR16","doi-asserted-by":"crossref","unstructured":"Tadros M. A., Fuglevand A. J., Brichta A. M., Callister R. J. Intrinsic excitability differs between murine hypoglossal and spinal motoneurons. J. Neurophysiol. https:\/\/doi.org\/10.1152\/jn.01114.2015 (2016).","DOI":"10.1152\/jn.01114.2015"},{"key":"553_CR17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/cne.23228","volume":"521","author":"J Yamada","year":"2013","unstructured":"Yamada, J. & Jinno, S. Novel objective classification of reactive microglia following hypoglossal axotomy using hierarchical cluster analysis. J. Comp. Neurol. 521, 1184\u20131201 (2013).","journal-title":"J. Comp. Neurol."},{"key":"553_CR18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/neu.2008.0661","volume":"26","author":"C Penas","year":"2009","unstructured":"Penas, C., Casas, C., Robert, I., For\u00e9s, J. & Navarro, X. Cytoskeletal and activity-related changes in spinal motoneurons after root avulsion. J. Neurotrauma 26, 763\u2013779 (2009).","journal-title":"J. Neurotrauma"},{"key":"553_CR19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0092-8674(00)80369-4","volume":"90","author":"C Sidrauski","year":"1997","unstructured":"Sidrauski, C. & Walter, P. The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell 90, 1031\u20131039 (1997).","journal-title":"Cell"},{"key":"553_CR20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/cr.2013.70","volume":"23","author":"AZ Herskovits","year":"2013","unstructured":"Herskovits, A. Z. & Guarente, L. Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Res. 23, 746\u2013758 (2013).","journal-title":"Cell Res."},{"key":"553_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","volume":"16","author":"A Vaquero","year":"2004","unstructured":"Vaquero, A. et al. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16, 93\u2013105 (2004).","journal-title":"Mol. Cell"},{"key":"553_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri, H. et al. hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 107, 149\u2013159 (2001).","journal-title":"Cell"},{"key":"553_CR23","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1074\/mcp.M116.061333","volume":"15","author":"HG Budayeva","year":"2016","unstructured":"Budayeva, H. G. & Cristea, I. M. Human sirtuin 2 localization, transient interactions, and impact on the proteome point to its role in intracellular trafficking. Mol. Cell. Proteom. 15, 3107\u20133125 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"553_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1001","volume":"1","author":"D Herranz","year":"2010","unstructured":"Herranz, D. et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 1, 1\u20138 (2010).","journal-title":"Nat. Commun."},{"key":"553_CR25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1101\/gad.211342.112","volume":"27","author":"L Serrano","year":"2013","unstructured":"Serrano, L. et al. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev. 27, 639\u2013653 (2013).","journal-title":"Genes Dev."},{"key":"553_CR26","doi-asserted-by":"crossref","first-page":"e0147626","DOI":"10.1371\/journal.pone.0147626","volume":"11","author":"M Herrando-Grabulosa","year":"2016","unstructured":"Herrando-Grabulosa, M. et al. Novel neuroprotective multicomponent therapy for amyotrophic lateral sclerosis designed by networked systems. PLoS ONE 11, e0147626 (2016).","journal-title":"PLoS ONE"},{"key":"553_CR27","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1038\/emboj.2013.200","volume":"32","author":"TF Pai","year":"2013","unstructured":"Pai, T.F. et al. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain. EMBO J. 32, 2603\u20132616 (2013).","journal-title":"EMBO J."},{"key":"553_CR28","doi-asserted-by":"crossref","unstructured":"Pintado C., Mac\u00edas S., Dom\u00ednguez-Mart\u00edn H., Casta\u00f1o A. & Ruano D. Neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation. Sci. Rep. 1\u201312 (2017).","DOI":"10.1038\/s41598-017-08722-3"},{"key":"553_CR29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s11064-016-2110-y","volume":"42","author":"H J\u0119\u015bko","year":"2017","unstructured":"J\u0119\u015bko, H., Wencel, P., Strosznajder, R. P. & Strosznajder, J. B. Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem. Res. 42, 876\u2013890 (2017).","journal-title":"Neurochem. Res."},{"key":"553_CR30","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","volume":"26","author":"D Kim","year":"2007","unstructured":"Kim, D. et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169\u20133179 (2007).","journal-title":"EMBO J."},{"key":"553_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.2559","volume":"18","author":"H Jeong","year":"2012","unstructured":"Jeong, H. et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 18, 159\u2013165 (2012).","journal-title":"Nat. Med."},{"key":"553_CR32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/ars.2017.7258","volume":"28","author":"N Khoury","year":"2018","unstructured":"Khoury, N., Koronowski, K. B., Young, J. I. & Perez-Pinzon, M. A. The NAD+-dependent family of sirtuins in cerebral ischemia and preconditioning. Antioxid. Redox Signal. 28, 691\u2013710 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"553_CR33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/cb100376q","volume":"6","author":"DM Taylor","year":"2011","unstructured":"Taylor, D. M. et al. A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase. ACS Chem. Biol. 6, 540\u2013546 (2011).","journal-title":"ACS Chem. Biol."},{"key":"553_CR34","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","volume":"107","author":"R Luthi-Carter","year":"2010","unstructured":"Luthi-Carter, R. et al. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc. Natl. Acad. Sci. USA 107, 7927\u20137932 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"553_CR35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro, T. F. et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science 317, 516\u2013519 (2007).","journal-title":"Science"},{"key":"553_CR36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cmdc.201402431","volume":"10","author":"P Di\u2005Fruscia","year":"2015","unstructured":"Di\u2005Fruscia, P. et al. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson\u2019s Disease Model. Chem. Med. Chem. 10, 69\u201382 (2015).","journal-title":"Chem. Med. Chem."},{"key":"553_CR37","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","volume":"17","author":"J Pallos","year":"2008","unstructured":"Pallos, J. et al. Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease. Hum. Mol. Genet. 17, 3767\u20133775 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"553_CR38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","volume":"2","author":"V Chopra","year":"2012","unstructured":"Chopra, V. et al. The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models. Cell Rep. 2, 1492\u20131497 (2012).","journal-title":"Cell Rep."},{"key":"553_CR39","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1242\/jcs.073783","volume":"123","author":"KM Rothgiesser","year":"2010","unstructured":"Rothgiesser, K. M., Erener, S., Waibel, S., L\u00fcscher, B. & Hottiger, M. O. SIRT2 regulates NF-\u03baB dependent gene expression through deacetylation of p65 Lys310. J. Cell Sci. 123, 4251\u20134258 (2010).","journal-title":"J. Cell Sci."},{"key":"553_CR40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbrc.2013.10.153","volume":"441","author":"J Lin","year":"2013","unstructured":"Lin, J., Sun, B., Jiang, C., Hong, H. & Zheng, Y. Sirt2 suppresses inflammatory responses in collagen-induced arthritis. Biochem. Biophys. Res. Commun. 441, 897\u2013903 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"553_CR41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jnc.13423","volume":"136","author":"F Yuan","year":"2016","unstructured":"Yuan, F. et al. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-??B p65 acetylation and activation. J. Neurochem. 136, 581\u2013593 (2016).","journal-title":"J. Neurochem."},{"key":"553_CR42","doi-asserted-by":"crossref","first-page":"e103573","DOI":"10.1371\/journal.pone.0103573","volume":"9","author":"G Lo Sasso","year":"2014","unstructured":"Lo Sasso, G. et al. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS ONE 9, e103573 (2014).","journal-title":"PLoS ONE"},{"key":"553_CR43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.freeradbiomed.2013.06.005","volume":"63","author":"MJ Kim","year":"2013","unstructured":"Kim, M. J. et al. PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes in murine macrophages. Free. Radic. Biol. Med. 63, 432\u2013445 (2013).","journal-title":"Free. Radic. Biol. Med."},{"key":"553_CR44","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbrc.2014.06.135","volume":"450","author":"AS Lee","year":"2014","unstructured":"Lee, A. S. et al. SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem. Biophys. Res. Commun. 450, 1363\u20131369 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"553_CR45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/WNR.0000000000000305","volume":"26","author":"H Chen","year":"2015","unstructured":"Chen, H., Wu, D., Ding, X. & Ying, W. SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. NeuroReport 26, 88\u201393 (2015).","journal-title":"NeuroReport"},{"key":"553_CR46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"553_CR47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/acel.12682","volume":"16","author":"S Fourcade","year":"2017","unstructured":"Fourcade, S. et al. Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance. Aging Cell 26, 1404\u20131413 (2017).","journal-title":"Aging Cell"},{"key":"553_CR48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nbd.2009.10.017","volume":"37","author":"M Ferrucci","year":"2010","unstructured":"Ferrucci, M. et al. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium. Neurobiol. Dis. 37, 370\u2013383 (2010).","journal-title":"Neurobiol. Dis."},{"key":"553_CR49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3940(02)01140-0","volume":"335","author":"C Haenggeli","year":"2002","unstructured":"Haenggeli, C. & Kato, A. C. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci. Lett. 335, 39\u201343 (2002).","journal-title":"Neurosci. Lett."},{"key":"553_CR50","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.neurobiolaging.2015.02.025","volume":"36","author":"E Gavil\u00e1n","year":"2015","unstructured":"Gavil\u00e1n, E. et al. Age-related dysfunctions of the autophagy lysosomal pathway in hippocampal pyramidal neurons under proteasome stress. Neurobiol. Aging 36, 1953\u20131963 (2015).","journal-title":"Neurobiol. Aging"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0553-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:00:07Z","timestamp":1671537607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0553-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0553-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"9 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: Concerns have been raised about the integrity of the data reported in this article. This is currently being investigated. Further editorial action may be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. NeuroHeal is currently under PCT extension.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"531"}}